Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-03-04 to 2025-03-05
Current total value of award: $22714.8
Description: 4567459560!NUCALA 100 MG/ML SYRINGEML